Back to results
US 10,329,292 B2Granted
Substituted xanthine derivatives
AssigneesBoehringer Ingelheim International GmbH, Hydra Biosciences, Inc.
InventorsKai Gerlach, Christian Eickmeier, Achim Sauer, Stefan Just, Bertrand L. Chenard
Life of this patent
Estimating the term…
Abstract
The present invention relates to substituted xanthine derivatives, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment of conditions having an association with TRPC5 containing ion channels.
Claims18
A compound, wherein the compound is:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.